Navigation Links
Vaginal progesterone gel may improve infant outcomes and...
Date:10/2/2007

20267">http://www3.interscience.wiley.com/cgi-bin/jhome/99020267.

Based on the statistically significant findings in the secondary analysis, we are moving forward with a follow-up study using PROCHIEVE 8%, stated Robert S. Mills, president and chief executive officer of Columbia Laboratories. It is estimated that of the more than 4.1 million live births in the U.S. each year, up to 30 percent of pregnant mothers have a cervical length less than or equal to 3.0 centimeters in mid-pregnancy. This includes many women with first-time pregnancies, the group that has the largest number of premature babies each year. We look forward to publishing the results of the next study.

A normal pregnancy is about 40 weeks. Preterm birth before 37 weeks gestation is a leading cause of infant and neonatal death, continues to rise, and occurs in more than 12 percent of pregnancies in the United States. The negative health effects of preterm birth go far beyond the first days of life; preterm birth is associated with a high prevalence of severe neurological deficits and developmental disabilities.

These negative health outcomes have economic implications, as well. A 2005 March of Dimes study found that employers pay nearly 15 times more in direct healthcare coverage costs for babies born prematurely in their first year of life than for full term babies, with an average cost of $41,610 for a premature baby vs. $2,830 for a healthy, full-term baby. In a separate analysis, the March of Dimes estimates that in 2002, almost half of hospital charges for premature infants, or about $7.4 billion, were billed to employers and other private insurers. This estimate was derived using the Nationwide Inpatient Sample from the Agency for Healthcare Research and Quality.

"Preterm birth has such a profound effect on both babies and their families that any research that can help us understand how to prevent preterm birth is a significant advance," said Susan
'/>"/>

Contact: Kathleen Cosgrove
kathleen.cosgrove@mslpr.com
617-937-2534
Columbia Laboratories, Inc.
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Vaginal Birth After C-section Dangerous For Both Mother And Baby
2. PET Scanner detects more Vaginal cancer than CT scans
3. Vaginal Vaccine may prevent periodic infections
4. A new approach to vaginal hysterectomy
5. Dermaseptins: Potent vaginal contraceptives
6. Vaginal atrophy drug Ospemifene found effective in breast cancer Prevention
7. US surge in vaginal reconstruction
8. Increased Risk Of HIV Transmission Following Vaginal Washing
9. Risk Of AIDS Rises With Vaginal Washes
10. Vaginal massage during pregnancy avoids Episiotomy procedure
11. Vaginal Gel That Protects Against HIV To Hit The Markets By 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2008)...Milk Mustache Campaign and Everyday Food Team ... WASHINGTON, May 22 /PRNewswire/ -- America, star...k Mustache Campaign and Everyday Food magazine,are...onor of June Dairy,Month., Whether it,s a sweet t...smoothie aficionados seeking a taste of fame are i...
(Date:5/22/2008)...ntal drug has blocked the progression of prostate ...of the disease, new research shows. , The agent, ... histone deacetylase (HDAC) inhibitors, compounds ... against cancer but are turned off by the cancer p...University Comprehensive Cancer Center researchers...
(Date:5/22/2008)...rch Foundation recently awarded its top honors to ...at the 2008 Spring Research Review Awards Dinner. ...ence was established in 1974 by the actress Dina M...e highest honor JDRF awards, and is presented annu...d commitment to diabetes research and for their se...
(Date:5/22/2008)...swire-USNewswire/ -- Many baby boomers,incorrectly...ccording to a,new survey conducted by Harris Inter...Plans (AHIP). Most say that disability insurance i...lf say they do not have any disability,income prot...rnh/20040830/AHIPLOGO ), "Baby boomers recognize...
Breaking Medicine News(10 mins):Health News:Thirsting for Healthful Smoothie Recipes That 'got milk?' 2Health News:Experimental agent blocks prostate cancer in animal study 2Health News:JDRF announces 2008 Spring Research Review Award 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 3
...ppear five times as likely as lean women to have p...es fertility and contributes to other// illnesses,...f Archives of Internal Medicine, one of the JAMA/A...ndrome occurs when the ovaries malfunction and lev...
...tric inpatient services, which will transfer from ...urpose-built facility will include 16 individual c...ll also include "bedside beds" for parents and a n...which is part of the plan to centralize children's...
...e to screen six-month-old infants for HIV. This in...g babies delivered from HIV infected// women. This...ics and one hospital. It is estimated that among ..., the infection rate as depicted by the Botswana A...
...ation Practices has made the recommendation on Wed...he shingles(herpes zoster) virus.// The vaccine i... approval for its use in May. It has a live virus ...han the children's chicken pox virus, also from Me...
Other Medicine News:Health News:Polycystic Ovary Syndrome More Prevalent in Overweight Women 2
(Date:5/21/2008)...First Presentation of Full Data Set from the TRIUM... Treprostinil, SILVER SPRING, Md., May 21 /PRNews... (Nasdaq: UTHR ) and its wholly-owned subsidiary,... presentations concerning,the treatment of pulmona...ere reported at the American Thoracic Society (ATS...
(Date:5/21/2008)... Innovative pipeline products highlight Watson,s c...oed Until 2:10 PM EDT, ORLANDO, Fla., May 21 /PRN... (NYSE: WPI ), a leading specialty pharmaceutical...nted clinical data on two Phase 3 products at,the ...The abstracts include,a cardiac safety trial invol...
(Date:5/21/2008)... Tumor responses, safety and long-term survivors...h product approach, SAN FRANCISCO and YONGIN-SI, ... (San Francisco, CA and Ottawa, Ontario), and its ...today that Phase I clinical,trial results from its... in,the premier journal Lancet Oncology. The major...
(Date:5/21/2008)... Findings Show Cystic Fibrosis Patients Cough More... -, SOUTH PLAINFIELD, N.J., May 21 /PRNews...ced new data suggesting that the quantification of... outcome measure in cystic,fibrosis (CF). Cough is...related symptoms in CF. According to data presente...
Breaking Medicine Technology:Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 2Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 3Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 4Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 5Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 6Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 2Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 4PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 2PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 4YouTube Video to Benefit AIDS Babies 4653 1CNA Presents New Data on Sutters Medical Redlining 4650 1CNA Presents New Data on Sutters Medical Redlining 4650 2CNA Presents New Data on Sutters Medical Redlining 4650 3Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 1Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 2Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 3Hospital Romance May Largely Be Fiction 4649 1Hospital Romance May Largely Be Fiction 4649 2Hospital Romance May Largely Be Fiction 4649 3
...- Forest,Laboratories, Inc. and PAION AG today ann... In Acute Ischemic Stroke) study with the,compound...,investigate the improvement of clinical outcome i... Desmoteplase within 3 to 9 hours,after onset of s...,efficacy endpoint (difference between active trea...
... Research,collaborators with Oncolytics Biotech In...r presentation covering REOLYSIN(R),clinical trial...,(ASCO) Annual Meeting, to be held June 1-5, 2007 ...tics, U.K. Phase I systemic,administration trial. ... Study of,Wild-Type Oncolytic Reovirus Administere...
Other Medicine Technology:Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2
Lumitex® LightMat® Surgical Illuminator improves visualization in deep cavity surgery. Flexible and malleable, it attaches easily to most retractors, bringing bright, cool area lighting where
...HELION family consists of four models in proven ha...ure you find the right solution for every applicat... of two or three mobile lamps also battery-powered...h on the lamp housing, the standard-plus models of...
The Sunnex Celestial Star™ light is ideal for surgical applications. The flexible design allows for easy angling and positioning. The space-saving structure is ideal for many facilities includi
... new small incision surgical light is an industry ... for many surgeons. The DeepSite provides 10,000-f...hes, and can be positioned with one hand at distan...t is not tethered to the surgeon, so it allows tot...
Medicine Products: